Collecting survey and health record information from people with Charcot-Marie-Tooth disease
Gathers survey answers and health records from people with Charcot-Marie-Tooth disease.
Key facts
- Who runs it
- Hereditary Neuropathy Foundation
- Where
- New York, United StatesSee the site
- Trial code
- Registry title
- Natural History Study for Charcot Marie Tooth Disease
- Status
- Recruiting
- People taking part
- 10,000 people, planned
- Started
- 1 Nov 2013
- Expected to end
- 31 Dec 2029
- Type of study
- Observational
- Record updated
- 17 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children, adolescents and adults who have, or may have, Charcot-Marie-Tooth disease (CMT) or another inherited nerve disease. Participants fill in a survey about their disease.
- Age
- Children, adolescents and adults.
- Sex
- All sexes can join.
- Disease stage
- A confirmed or suspected diagnosis of CMT or another inherited neuropathy (nerve disease that runs in families). The diagnosis can come from family history, standard tests such as a nerve exam, EMG or NCS, or genetic testing.
- Biomarker or test result
- A genetic test is not required. Many gene changes have not been found yet.
Main reasons for not taking part
- People who do not have Charcot-Marie-Tooth or another inherited neuropathy cannot join.
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Patients will be made aware of the study by HNF and others (referenced above) and invited to participate. Once patients have reviewed and signed electronically the informed consent document, it is attached to their file
- All affected individuals with CMT/IN are eligible to participate in GRIN with proper informed consent
- Children, adolescents and adults with either a confirmed diagnosis or suspected to have CMT/IN are eligible with parent and/or guardian consent
- Individuals that have been clinically diagnosed through family history and/or standard clinical testing (e.g. neuro exam, EMG, NCS) and/or genetically tested or suspected to have CMT/IN (note: many mutations have not been identified yet) are eligible
Who cannot take part
- People that do not have Charcot-Marie-Tooth or other Inherited Neuropathies
Where in United States
- Hereditary Neuropathy FoundationNew York, United StatesContact: Allison MooreTaking people
About the trial
What the trial wants to find out
The goal of this Natural History Study for Charcot-Marie-Tooth is to acquire, record, and analyze patient-reported data and associated genetic reports, Electronic Health Records (EHRs) and clinical notes to identify the burden, diagnostic journey, and prevalence of disease that will aid scientists in their work toward finding a cure.
Read full original descriptionShow less
Participants will be asked to complete a Natural History Survey.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Global Registry for Inherited Neuropathies Natural History Study for Charcot Marie Tooth Disease
- Plain-language title
- Collecting survey and health record information from people with Charcot-Marie-Tooth diseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 17 September 2026